Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever: Impact on management of enteric fever

Jordan P. Skittrall, David Levy, Christian Obichukwu, Amy Gentle, Marie A. Chattaway, David Hayns, Clare Etheridge, Christopher Parry, Vanessa Wong, James Whitehorn

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Background: Drug-resistant enteric fever is increasingly common in the Indian subcontinent. Correctly determining azithromycin resistance matters where drug-resistant enteric fever is common and oral therapy necessary. Case report: In two patients returning from Pakistan to the UK with cephalosporin-resistant Salmonella enterica serovar Typhi, gradient strip testing erroneously indicated azithromycin resistance; the errors were detected by repeat testing and confirmed by whole genome sequencing. Results: Both patients were treated with meropenem and, when revised susceptibility results were known, with azithromycin, allowing a switch to oral therapy. Conclusion: As cephalosporin resistance becomes more common, azithromycin will be key for treating enteric fever and optimizing practice in susceptibility testing will be crucial. Practitioners should be aware of key steps to minimize error in azithromycin susceptibility testing, and should be alert for possible errors when reported azithromycin resistance is discordant with known prevalence of resistance.
Original languageEnglish
Article number100069
JournalClinical Infection in Practice
Volume10
DOIs
Publication statusPublished - 1 Apr 2021
Externally publishedYes

Keywords

  • Azithromycin
  • Drug Resistance, Microbial
  • Microbial Sensitivity Tests
  • Salmonella Infections
  • Typhoid Fever

Fingerprint

Dive into the research topics of 'Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever: Impact on management of enteric fever'. Together they form a unique fingerprint.

Cite this